LABSLibrary / Biohacking

Peptides Primer

BPC-157, TB-500, Semaglutide, and beyond: clinical context, regulatory status, and what the evidence does and does not support.

Biohacking4 min read5 sourcesUpdated Nov 15, 2026
BPC-157Top healing peptide
GHK-CuCopper peptide
FDARegulatory shifts
RxPhysician-supervised

Why it matters

Peptides are short amino acid chains (2-50 AA) that act as signaling molecules. Different peptides target different receptors: healing, GH secretion, immune modulation, cognition. The space is rapidly evolving and largely unregulated. Some have strong preclinical evidence; very few have robust human RCT data. The FDA has increased enforcement since 2023. Approach with informed caution, not blind enthusiasm.

Deep dive

01

Key peptides & evidence levels

BPC-157, GHK-Cu, TB-500, and GH secretagogues: what's proven and what's not.

  • BPC-157 (Body Protection Compound): derived from gastric juice. Preclinical studies show remarkable tissue repair, gut healing, and anti-inflammatory effects. However: virtually all evidence is from animal studies. Zero published human RCTs as of 2026. Promising but not proven in humans. Oral and injectable forms available.
  • GHK-Cu (Copper Peptide): naturally occurring tripeptide that declines with age. Strongest evidence is topical: wound healing, collagen stimulation, skin rejuvenation with actual human data. Subcutaneous use for systemic effects is less established but under investigation.
  • TB-500 (Thymosin Beta-4 fragment): promotes tissue repair and angiogenesis (new blood vessel formation). Used extensively in sports medicine and equine medicine. Human evidence is limited to case reports and small studies. Often paired with BPC-157.
  • GH Secretagogues (Ipamorelin, CJC-1295, Tesamorelin): stimulate natural growth hormone release from the pituitary. Better safety profile than exogenous GH. Tesamorelin is FDA-approved for HIV lipodystrophy. Others are research-use compounds with growing clinical interest.
02

Safety, sourcing & regulatory reality

FDA enforcement, compounding pharmacy sourcing, and why this isn't DIY.

  • FDA restrictions are tightening: since 2023, the FDA has been restricting compounding pharmacy access to several popular peptides. BPC-157 and some GH secretagogues face increasing scrutiny. The regulatory landscape is changing rapidly: what's available today may not be tomorrow.
  • Only use licensed compounding pharmacies: gray-market vendors (research peptide websites) carry contamination, mislabeling, and dosing risks. Compounding pharmacies with third-party testing and physician oversight are the only responsible source. Ask for certificates of analysis.
  • Work with a knowledgeable physician: peptides should be prescribed and monitored by a doctor experienced in peptide therapy. Blood work before, during, and after courses. This is not a supplement you order online: it's a medical intervention requiring clinical judgment.
  • Evidence hierarchy matters: distinguish between animal studies (preclinical), case reports (anecdotal), small human trials (preliminary), and large RCTs (established). Most peptide evidence sits in the preclinical-to-preliminary range. Honesty about this protects you from hype-driven decisions.

Stacking

Training

BPC-157 and TB-500 are most commonly used for injury repair in conjunction with rehab protocols.

Sleep

GH secretagogues are typically dosed before bed to align with natural GH pulsatility during deep sleep.

Glutathione

Peptide metabolism creates oxidative load. GSH supports detoxification pathways.

Protein

Adequate protein intake provides the amino acid substrates for peptide signaling.

Lab Work

Blood panels before, during, and after peptide courses. IGF-1, metabolic panel, CBC at minimum.

Put it into practice

Checklist

  • Working with a physician experienced in peptide therapy
  • Sourced from a licensed compounding pharmacy (not gray market)
  • Verified certificate of analysis for purity and potency
  • Completed baseline blood work before starting (IGF-1, metabolic, CBC)
  • Following prescribed dosing protocol exactly
  • Storing peptides properly (refrigerated, protected from light)
  • Tracking subjective and objective responses
  • Scheduled follow-up blood work (4-8 weeks into course)
  • Aware of current FDA regulatory status for my specific peptide
  • Not self-prescribing or adjusting doses without physician guidance

The evidence

Key sources

  1. Sikiric, P. et al. (2018). BPC-157 therapy and pharmacology. Curr Pharm Des.Find this source (opens Google Scholar in a new tab)
  2. Pickart, L. et al. (2015). GHK-Cu as a potential anti-aging peptide. AIMS Molecular Science.Find this source (opens Google Scholar in a new tab)
  3. Fosgerau, K. & Hoffmann, T. (2015). Peptide therapeutics: current status. Drug Discov Today, 20 (1).Find this source (opens Google Scholar in a new tab)
  4. Seeds, W. (2020). The Peptide Protocols.Find this source (opens Google Scholar in a new tab)
  5. FDA (2023-2026). Guidance on compounding pharmacy peptide regulations.Find this source (opens Google Scholar in a new tab)

Education, not medical advice. Talk with your clinician before changing medication, supplements or training, especially if you are pregnant, managing a condition or taking prescriptions. Updated Nov 15, 2026.

Take the free LABS Score

Founding list

Make it a habit.

Join the founding list for the free New Year challenge: one lever at a time, with a cohort doing it alongside you.

  • December 2026: founding preview
  • January 2027: public launch and New Year challenge
  • January 2027: the LABS Tampa Retreat
What brings you to LABS? Choose any that fit.

Free. No card. We never sell your data.

Ask COACH